Candel Therapeutics names Mark Sims as chief commercial officer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. SPGI
4. USO
5. AAPL
6. ENOV
7. AON
8. AZN
9. BLSM
10. KRMN

Go back to Candel Therapeutics names Mark Sims as chief commercial officer
(NASDAQ: CADL) Delayed: 12.93 -0.14 (1.07%)
Previous Close $13.07    52 Week High $ 
Open $12.93    52 Week Low $ 
Day High $13.04    P/E N/A 
Day Low $12.60    EPS $ 
Volume 574,264